We show here that gene expression profiling, performed with conventional techniques and focused on a selected group of genes, when used in combination with standard clinical information, provides reliable prognostic prediction of prostate cancer (Cap). We showed previously that changes in the expression of metabolically related genes are involved in CaP progression. We then proceeded to search further for correlations between patients' gene profiling and recurrence with a 5-year follow-up study conducted on the same cohort of patients in which the molecular data were obtained. CaP prognosis was first assessed on the basis of gene expression profiling alone; then the result was compared with the prediction obtained using clinical and pathological information (Gleason score, Tumor-Node-Metastasis staging, prostate volume, or prostate-specific antigen levels at the time of diagnosis). The best result was obtained with a selected, combination of gene profiling and clinical/pathological parameters, which resulted in prediction of recurrence in 95.7% of patients.

Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study / S., Bettuzzi; M., Scaltriti; A., Caporali; M., Brausi; D'Arca, Domenico; S., Astancolle; P., Davalli; A., Corti. - In: CANCER RESEARCH. - ISSN 0008-5472. - STAMPA. - 63:(2003), pp. 3469-3472.

Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study.

D'ARCA, Domenico;
2003

Abstract

We show here that gene expression profiling, performed with conventional techniques and focused on a selected group of genes, when used in combination with standard clinical information, provides reliable prognostic prediction of prostate cancer (Cap). We showed previously that changes in the expression of metabolically related genes are involved in CaP progression. We then proceeded to search further for correlations between patients' gene profiling and recurrence with a 5-year follow-up study conducted on the same cohort of patients in which the molecular data were obtained. CaP prognosis was first assessed on the basis of gene expression profiling alone; then the result was compared with the prediction obtained using clinical and pathological information (Gleason score, Tumor-Node-Metastasis staging, prostate volume, or prostate-specific antigen levels at the time of diagnosis). The best result was obtained with a selected, combination of gene profiling and clinical/pathological parameters, which resulted in prediction of recurrence in 95.7% of patients.
63
3469
3472
Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study / S., Bettuzzi; M., Scaltriti; A., Caporali; M., Brausi; D'Arca, Domenico; S., Astancolle; P., Davalli; A., Corti. - In: CANCER RESEARCH. - ISSN 0008-5472. - STAMPA. - 63:(2003), pp. 3469-3472.
S., Bettuzzi; M., Scaltriti; A., Caporali; M., Brausi; D'Arca, Domenico; S., Astancolle; P., Davalli; A., Corti
File in questo prodotto:
File Dimensione Formato  
Cancer Res-2003-Bettuzzi-3469-72.pdf

non disponibili

Descrizione: Articolo principale
Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 120.11 kB
Formato Adobe PDF
120.11 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/624578
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 27
social impact